
Numbers released by the Office for National Statistics (ONC) has revealed that drug misuse deaths were at a record high, …

The uncertainty caused by Brexit has been and continues to be far-reaching, and perhaps most impactful for business, organisations and …

Daiichi Sankyo has settled a case alleging that it did not fully disclose adverse side-effects of its drug, Benicar, with …

Pfizer revealed in its briefing on its second quarter financials that Ibrance, its breast cancer treatment, had grown in sales …

Pfizer has had a tough time keeping hold of its Vice President’s involved in R&D of late, losing high-profile researcher, …

It’s been a rollercoaster week for AstraZeneca.

Boehringer Ingelheim announced that it had broken ground on its planned $217 million upgrade and expansion of its existing Fermont …

As of today, all babies born in the UK will be administered with the vaccine for hepatitis B, with the …

Torbay Pharmaceuticals conducted a grand unveiling to open its £26 million pharmaceuticals manufacturing unit – the largest NHS manufacturer of …

Last month saw the formation of the Brexit Health Alliance, a partnering of key pharma and life sciences organisations including …

The reputation of large pharma companies in the UK was revealed to be well below the global average, in PatientView’s …

Through digital media and technology, the patient’s voice is only growing in strength and it is of growing importance that …

Researchers have found that offering first-time patients a HIV test in an area of high-prevalence could help reduce levels of …

Still reeling from the public reaction to the flop of its key Mystic trial, where its injectable immunotherapy drug Imfinzi …

The FDA has reputation worldwide as being a standard bearer when it comes to regulating the safety of products and …